Venous Phade Dual Energy Computed Tomography in Patients Suspected for Pulmonary Embolism: Diagnostic Accuracy and Evaluation of Incidental Findings.
Sponsor study identifier
interventional
160
1 country
2
Study Start
January 1, 2021
Actual (reported)Primary Completion
December 31, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 31, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Venous phase spectral or dual energy (DE) chest computed tomography (CT) in patients with suspected pulmonary embolism (PE) compared to standard computed tomography pulmonary angiography (CTPA): sensitivity, evaluation of iodine mapping and incidental findings.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2021
Actual (reported)April 20, 2021
Actual (reported)April 26, 2021
Actual (reported)December 31, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 31, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Sensitivity
Per patient sensitivity of portal venous phase chest DECT in diagnosing PE compared to the corresponding reference CTPA
through study completion, approx. of 1 year
Specificity
Per patient specificity of portal venous phase chest DECT in diagnosing PE compared to the corresponding reference CTPA
through study completion, approx. 1 year
Sensitivity
through study completion, approx. of 1 year
All patients undergo the same CT protocol in addition to standard care.
Each patient undergoes an additional dual energy / spectral chest CT in addition to standard care CTPA. The intervention is performed immediately after standard care CTPA.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Copenhagen University Gentofte Hospital
Copenhagen, Hellerup, 2900, Denmark
Copenhagen University Hospital, Herlev Hospital
Copenhagen, Herlev, 2400, Denmark
Yecatarina Z Rohde, MD
Copenhagen University Herlev Hospital
First Submitted
April 20, 2021
First Posted
April 26, 2021
Study Start
January 1, 2021
Actual (reported)Primary Completion
December 31, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The PEERLESS Study
Specificity
through study completion, approx. of 1 year
Incidental findings
through study completion, approx. of 1 year
Iodine mapping
through study completion, approx. of 1 year
Contact the study team to confirm eligibility.
Study Completion
December 31, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
April 26, 2021
Record last verified: 2021-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: